Treatment of locally advanced (T2-3N0-1M0) and early (T1-2N0M0) HER2-positive breast cancer (clinical experience)
V.F. Semiglazov Semiglazov, A.V. Komyakhov Komyakhov, S.S. Ereshchenko Ereshchenko, T.T. Tabagua Tabagua,L.P. Gigolaeva Gigolaeva, A.I. Tseluyko Tseluyko, A.P. Tergoeva Tergoeva, M.D. Kazantseva Kazantseva, N.S. Amirov Amirov, V.V. Mortada Mortada, R.S. Pesotsky Pesotsky, D.A. Enaldieva Enaldieva, L.F. Shaikhelislamova Shaikhelislamova,K.S. Nikolaev Nikolaev, E.K. Zhiltsova Zhiltsova,P.V. Krivorotko Krivorotko Pharmateca（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
